+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-05-04Number of Pages: 243

Vascular Graft Market (Product - Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, and Bypass Graft; End User - Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Cardiac Catheterization Laboratories; Source - Synthetic, Biosynthetic and Biological; Application - Coronary Artery Disease, Aneurysm, Vascular Occlusion, and Renal Failure) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Vascular Graft Market: Snapshot 

Vascular graft has been a prosthetic of choice among the vascular and other cardiovascular surgeons worldwide due to its strong, inert and biocompatible design which also varies in sizes and configurations in order to improve vascular access. The rise in vascular graft usage has been increased due to increase in cardiovascular diseases and diabetes. Increase in geriatric population, demand of new technological advancements in vascular access, rise in demand of vascular grafts among vascular patients can also accelerate the growth in vascular graft market. Risk of infection due to diabetes mellitus and immune response can increase some serious complications such as sepsis, amputation, disruption of infected anastomotic rigid line with a rupture, etc. can restrain the market growth.  

The global vascular graft market is forecast to reach US$3.29 bn by the end of 2024, from US$2.15 bn in 2015. If these figures hold true, the global vascular grafts market will exhibit a CAGR of 5.0% between 2016 and 2024. 

Global  Vascular Graft Market

Hospitals Emerge as Leading End Users of Vascular Grafts 

Based on product, the vascular graft market is segmented as endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft and others. The endovascular stent graft segment dominated the global vascular graft market accounting for the share of 41.0% in 2015 as these devices are mostly utilized by the vascular surgeons for abnormal aortic disorders or aneurysm caused due to cardiovascular disorders or diabetes, and smoking. The hemodialysis segment is also expected to register the fastest growth during the forecast period due to increase in number of diabetes patients. Bypass graft segment is projected to grow with a second highest CAGR between 2016 and 2024 due to increase in number of incidences of coronary artery diseases caused due to increase in obesity and unhealthy food habits. 

Vascular grafts are used by various end users including hospitals, ambulatory surgical centers, specialty clinics, cardiac catheterization laboratories, and others. The hospital end user segment held the largest market share in 2015 owing to increasing incidence of cardiovascular disease, introduction of technological modification on grafts by different key players in the form of usage of different sources. The segment is also projected to grow at the fastest CAGR within the end user segment. The major factor driving the hospital end user segment is that most of the vascular graft with latest technological source & design availability in hospitals. Furthermore, continuous rise in the incidence of diabetes, cardiovascular disease are also expected to boost the growth of hospital segment during the forecast period from 2016 to 2024. Based on the source segment, synthetic vascular graft is expected to have higher market share by 2024 in compare to biological and biosynthetic vascular grafts. Vascular grafts are also used for various application including coronary artery disease; aneurysm; vascular occlusion; renal failure, and others. The coronary artery disease segment is likely to grow with higher CAGR between 2016 and 2024. 

Technological Developments Enabling North America Vascular Graft Market to Exhibit Strong Growth 

The global vascular graft market has been segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa., which are further categorized into various countries under each region. North America dominated the global vascular graft market in 2015 with a share of 45.0% due to factors such as increasing prevalence of cardiovascular diseases and better healthcare awareness program for diabetes. Furthermore, technological developments and increasing expenditure by major key players for development of vascular graft are also boosting the growth of the vascular graft market in North America. 

According to the Journal of BioMed Research International, (2013), cardiovascular diseases (CVD) cause 3% of all deaths in North America. Also, the American Heart Association (AHA) policy statement concluded that cardiovascular disease treatment cost will rise to US$ 1 trillion annually in the U.S. by 2030 which can increase the demand in various cardiovascular devices which is likely to drive the growth of the vascular graft market. 

However, Asia Pacific is projected to highest growth rate over the forecast period. The rationale behind such high growth has been attributed due to increase in geriatric population, set up of distribution channels by key players. Moreover, improving healthcare infrastructure and medical tourism would also drive the growth of the vascular graft market in the next few years.

W.L. Gore & Associates, Inc. dominated the global vascular graft market in 2015. Major factors attributed to its dominance are product portfolio and widespread market presence. Other players in the global vascular graft market include Vascular Grafts Solutions Ltd., Heart Medical Europe BV, C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG (Getinge Group), Cook Medical, Inc., B. Braun Melsungen AG, Medtronic plc, LeMaitre Vascular, Inc., ARTEGRAFT, Vascutek Ltd. (Terumo Company) and others. 

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vascular Grafts Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Vascular Grafts Market Analysis and Forecasts,2014–2024
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Market Outlook
     4.8.Global Prevalence of Chronic Kidney Diseases
     4.9.Prevalence of End Stage Renal Disorders 
     4.10.Patient Data for Dialysis (2016)
            4.10.1. Hemodialysis 
            4.10.2. Peritoneal Dialysis 
     4.11. Global Prevalence of Cardiovascular Diseases
     4.12. Overview of Cryopreservation Technique

5. Global Vascular Grafts Market Analysis and Forecasts, By Product Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product Type, 2014–2024
            5.4.1. Endovascular Stent Graft 
            5.4.2. Peripheral Vascular Graft 
            5.4.3. Hemodialysis Access Graft 
            5.4.4. Bypass Graft 
            5.4.5. Others
     5.5. Market Attractiveness By Product Type 

6. Global Vascular Grafts Market Analysis and Forecasts, By Source 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Source, 2014–2024
            6.4.1. Synthetic 
                     6.4.1.1. Polytetrafluethylene (PTFE)
                     6.4.1.2. Polyurethane (PU)
                     6.4.1.3. Dacron
                     6.4.1.4. Others
            6.4.2. Biological 
                     6.4.2.1. Bovine Vein
                     6.4.2.2. Saphenous Vein
                     6.4.2.3. Others
            6.4.3. Biosynthetic 
                     6.4.3.1. Ovine Collagen with Polyesters 
                     6.4.3.2. Others
     6.5. Market Attractiveness By Source 

7. Global Vascular Grafts Market Analysis and Forecasts, By Applications 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By Applications, 2014–2024
            7.4.1. Coronary Artery Disease
            7.4.2. Aneurysm
            7.4.3. Vascular Occlusion
            7.4.4. Renal Failure 
            7.4.5. Others
     7.5. Market Attractiveness By Applications

8. Global Vascular Grafts Market Analysis and Forecasts, By End Users 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value Forecast By End Users , 2014–2024
            8.4.1. Hospitals
            8.4.2. Ambulatory Surgery Centers
            8.4.3. Cardiac Catheterization Laboratories 
            8.4.4. Specialty Clinics 
            8.4.5. Others
     8.5. Market Attractiveness By End Users 

9. Global Vascular Grafts Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Value Forecast By Region
            9.3.1. North America 
            9.3.2. Europe 
            9.3.3. Asia Pacific 
            9.3.4. Latin America 
            9.3.5. Middle East & Africa 
     9.4. Market Attractiveness By Country/Region

10. North America Vascular Grafts Market Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2.Market Value Forecast By Product Type, 2014–2024
            10.2.1. Endovascular Stent Graft 
            10.2.2. Peripheral Vascular Graft 
            10.2.3. Hemodialysis Access Graft 
            10.2.4. Bypass Graft 
            10.2.5. Others
     10.3.Market Value Forecast By Source, 2014–2024
            10.3.1. Synthetic 
                     10.3.1.1. Polytetrafluethylene (PTFE)
                     10.3.1.2. Polyurethane (PU)
                     10.3.1.3. Dacron
                     10.3.1.4. Others
            10.3.2. Biological 
                     10.3.2.1. Bovine Vein
                     10.3.2.2. Saphenous Vein
                     10.3.2.3. Others
            10.3.3. Biosynthetic 
                     10.3.3.1. Ovine Collagen with Polyesters 
                     10.3.3.2. Others
     10.4.Market Value Forecast By Applications, 2014–2024
            10.4.1. Coronary Artery Disease
            10.4.2. Aneurysm
            10.4.3. Vascular Occlusion
            10.4.4. Renal Failure 
            10.4.5. Others
     10.5.Market Value Forecast By End Users, 2014–2024
            10.5.1. Hospitals
            10.5.2. Ambulatory Surgery Centers
            10.5.3. Cardiac Catheterization Laboratories 
            10.5.4. Specialty Clinics 
            10.5.5. Others
     10.6.Market Value Forecast By Country, 2014–2024
            10.6.1. U.S.
            10.6.2. Canada
     10.7.Market Attractiveness Analysis 
            10.7.1. By Product Type 
            10.7.2. By Source 
            10.7.3. By Applications
            10.7.4. By End Users 
            10.7.5. By Country

11. Europe Vascular Grafts Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Key Trends
     11.2.Market Value Forecast By Product Type, 2014–2024
            11.2.1. Endovascular Stent Graft 
            11.2.2. Peripheral Vascular Graft 
            11.2.3. Hemodialysis Access Graft 
            11.2.4. Bypass Graft 
            11.2.5. Others
     11.3.Market Value Forecast By Source, 2014–2024
            11.3.1. Synthetic 
                     11.3.1.1. Polytetrafluethylene (PTFE)
                     11.3.1.2. Polyurethane (PU)
                     11.3.1.3. Dacron
                     11.3.1.4. Others
            11.3.2. Biological 
                     11.3.2.1. Bovine Vein
                     11.3.2.2. Saphenous Vein
                     11.3.2.3. Others
            11.3.3. Biosynthetic 
                     11.3.3.1. Ovine Collagen with Polyesters 
                     11.3.3.2. Others
     11.4.Market Value Forecast By Applications, 2014–2024
            11.4.1. Coronary Artery Disease
            11.4.2. Aneurysm
            11.4.3. Vascular Occlusion
            11.4.4. Renal Failure 
            11.4.5. Others
     11.5.Market Value Forecast By End Users, 2014–2024
            11.5.1. Hospitals
            11.5.2. Ambulatory Surgery Centers
            11.5.3. Cardiac Catheterization Laboratories 
            11.5.4. Specialty Clinics 
            11.5.5. Others
     11.6.Market Value Forecast By Country, 2014–2024
            11.6.1. Germany 
            11.6.2. U.K.
            11.6.3. France
            11.6.4. Italy 
            11.6.5. Spain
            11.6.6. Russia
            11.6.7. Rest of Europe
     11.7.Market Attractiveness Analysis 
            11.7.1. By Product Type 
            11.7.2. By Source 
            11.7.3. By Applications 
            11.7.4. By End Users 
            11.7.5. By Country

12. Asia Pacific Vascular Grafts Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2.Market Value Forecast By Product Type, 2014–2024
            12.2.1. Endovascular Stent Graft 
            12.2.2. Peripheral Vascular Graft 
            12.2.3. Hemodialysis Access Graft 
            12.2.4. Bypass Graft 
            12.2.5. Others
     12.3.Market Value Forecast By Source, 2014–2024
            12.3.1. Synthetic 
                     12.3.1.1. Polytetrafluethylene (PTFE)
                     12.3.1.2. Polyurethane (PU)
                     12.3.1.3. Dacron
                     12.3.1.4. Others
            12.3.2. Biological 
                     12.3.2.1. Bovine Vein
                     12.3.2.2. Saphenous Vein
                     12.3.2.3. Others
            12.3.3. Biosynthetic 
                     12.3.3.1. Ovine Collagen with Polyesters 
                     12.3.3.2. Others
     12.4.Market Value Forecast By Applications, 2014–2024
            12.4.1. Coronary Artery Disease
            12.4.2. Aneurysm
            12.4.3. Vascular Occlusion
            12.4.4. Renal Failure 
            12.4.5. Others
     12.5.Market Value Forecast By End Users, 2014–2024
            12.5.1. Hospitals
            12.5.2. Ambulatory Surgery Centers
            12.5.3. Cardiac Catheterization Laboratories 
            12.5.4. Specialty Clinics 
            12.5.5. Others
     12.6.Market Value Forecast By Country, 2014–2024
            12.6.1. China 
            12.6.2. India
            12.6.3. Japan 
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific
     12.7.Market Attractiveness Analysis 
            12.7.1. By Product Type 
            12.7.2. By Source 
            12.7.3. By Applications
            12.7.4. By End Users 
            12.7.5. By Country

13. Latin America Vascular Grafts Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2.Market Value Forecast By Product Type, 2014–2024
            13.2.1. Endovascular Stent Graft 
            13.2.2. Peripheral Vascular Graft 
            13.2.3. Hemodialysis Access Graft 
            13.2.4. Bypass Graft 
            13.2.5. Others
     13.3.Market Value Forecast By Source, 2014–2024
            13.3.1. Synthetic 
                     13.3.1.1. Polytetrafluethylene (PTFE)
                     13.3.1.2. Polyurethane (PU)
                     13.3.1.3. Dacron
                     13.3.1.4. Others
            13.3.2. Biological 
                     13.3.2.1. Bovine Vein
                     13.3.2.2. Saphenous Vein
                     13.3.2.3. Others
            13.3.3. Biosynthetic 
                     13.3.3.1. Ovine Collagen with Polyesters 
                     13.3.3.2. Others
     13.4.Market Value Forecast By Applications, 2014–2024
            13.4.1. Coronary Artery Disease
            13.4.2. Aneurysm
            13.4.3. Vascular Occlusion
            13.4.4. Renal Failure 
            13.4.5. Others
     13.5.Market Value Forecast By End Users, 2014–2024
            13.5.1. Hospitals
            13.5.2. Ambulatory Surgery Centers
            13.5.3. Cardiac Catheterization Laboratories 
            13.5.4. Specialty Clinics 
            13.5.5. Others
     13.6.Market Value Forecast By Country, 2014–2024
            13.6.1. Brazil
            13.6.2. Mexico 
            13.6.3. Rest of Latin America
     13.7.Market Attractiveness Analysis 
            13.7.1. By Product Type 
            13.7.2. By Source 
            13.7.3. By Applications
            13.7.4. By End Users 
            13.7.5. By Country

14. Middle East & Africa Vascular Grafts Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
            14.1.2. Policies and Regulations
            14.1.3. Key Trends
     14.2.Market Value Forecast By Product Type, 2014–2024
            14.2.1. Endovascular Stent Graft 
            14.2.2. Peripheral Vascular Graft 
            14.2.3. Hemodialysis Access Graft 
            14.2.4. Bypass Graft 
            14.2.5. Others
     14.3.Market Value Forecast By Source, 2014–2024
            14.3.1. Synthetic 
                     14.3.1.1. Polytetrafluethylene (PTFE)
                     14.3.1.2. Polyurethane (PU)
                     14.3.1.3. Dacron
                     14.3.1.4. Others
            14.3.2. Biological 
                     14.3.2.1. Bovine Vein
                     14.3.2.2. Saphenous Vein
                     14.3.2.3. Others
            14.3.3. Biosynthetic 
                     14.3.3.1. Ovine Collagen with Polyesters 
                     14.3.3.2. Others
     14.4.Market Value Forecast By Applications, 2014–2024
            14.4.1. Coronary Artery Disease
            14.4.2. Aneurysm
            14.4.3. Vascular Occlusion
            14.4.4. Renal Failure 
            14.4.5. Others
     14.5.Market Value Forecast By End Users, 2014–2024
            14.5.1. Hospitals
            14.5.2. Ambulatory Surgery Centers
            14.5.3. Cardiac Catheterization Laboratories 
            14.5.4. Specialty Clinics 
            14.5.5. Others
     14.6.Market Value Forecast By Country, 2014–2024
            14.6.1. GCC Countries
            14.6.2. South Africa 
            14.6.3. Rest of Middle East & Africa
     14.7.Market Attractiveness Analysis 
            14.7.1. By Product Type 
            14.7.2. By Source 
            14.7.3. By Applications
            14.7.4. By End Users 
            14.7.5. By Country

15. Competition Landscape
     15.1.Market Player – Competition Matrix (By Tier and Size of
     companies)
     15.2.Market Share Analysis, By Company - 2016 (Estimated)
     15.3.Company Profiles (Details – Overview, Financials, 
     Recent Developments, Strategy)
            15.3.1. LeMaitre Vascular, Inc.
                     15.3.1.1. Overview
                     15.3.1.2. Financials
                     15.3.1.3. Recent Developments
                     15.3.1.4. Strategy
            15.3.2. ARTEGRAFT
                     15.3.2.1. Overview
                     15.3.2.2. Financials
                     15.3.2.3. Recent Developments
                     15.3.2.4. Strategy
            15.3.3. Vascutek Ltd.
                     15.3.3.1. Overview
                     15.3.3.2. Financials
                     15.3.3.3. Recent Developments
                     15.3.3.4. Strategy 
            15.3.4. W. L. Gore & Associates, Inc.
                     15.3.4.1. Overview
                     15.3.4.2. Financials
                     15.3.4.3. Recent Developments
                     15.3.4.4. Strategy
            15.3.5. Vascular Grafts Solutions Ltd.
                     15.3.5.1. Overview
                     15.3.5.2. Financials
                     15.3.5.3. Recent Developments
                     15.3.5.4. Strategy
            15.3.6. Heart Medical Europe BV
                     15.3.6.1. Overview
                     15.3.6.2. Financials
                     15.3.6.3. Recent Developments
                     15.3.6.4. Strategy
            15.3.7. C.R. Bard, Inc.
                     15.3.7.1. Overview
                     15.3.7.2. Financials
                     15.3.7.3. Recent Developments
                     15.3.7.4. Strategy
            15.3.8. MAQUET Holding B.V. & Co. KG
                     15.3.8.1. Overview
                     15.3.8.2. Financials
                     15.3.8.3. Recent Developments
                     15.3.8.4. Strategy
            15.3.9. CryoLife Inc.
                     15.3.9.1. Overview
                     15.3.9.2. Financials
                     15.3.9.3. Recent Developments
                     15.3.9.4. Strategy
            15.3.10. Cook Medical, Inc.
                     15.3.10.1. Overview
                     15.3.10.2. Financials
                     15.3.10.3. Recent Developments
                     15.3.10.4. Strategy
            15.3.11. B. Braun Melsungen AG
                     15.3.11.1. Overview
                     15.3.11.2. Financials
                     15.3.11.3. Recent Developments
                     15.3.11.4. Strategy
            15.3.12. Medtronic plc
                     15.3.12.1. Overview
                     15.3.12.2. Financials
                     15.3.12.3. Recent Developments
                     15.3.12.4. Strategy 
            15.3.13. Others
                     15.3.13.1. Overview
                     15.3.13.2. Financials
                     15.3.13.3. Recent Developments
                     15.3.13.4. Strategy

16. Key Take Aways

List of Figures

FIG 01: Global Vascular Graft Market Size (US$ Mn) Forecast, 2014–2024
FIG 02: Vascular Graft Market Value Share, by Product (2016)
FIG 03: Vascular Graft Market Value Share, by Application (2016)
FIG 04: Vascular Graft Market Value Share, by End-user (2016)
FIG 05: Vascular Graft Market Value Share, by Source (2016)
FIG 06: Vascular Graft Market Value Share, by Region (2016)
FIG 07: Global Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 08: Global Vascular Graft Market Attractiveness, by Product, 2016-2024
FIG 09: Global Vascular Graft Market, By Endovascular Stent Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 10: Global Vascular Graft Market, By Peripheral Vascular Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 11: Global Vascular Graft Market, By Hemodialysis Access Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 12: Global Vascular Graft Market, By Bypass Graft Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 13: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 14: Global Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 15: Global Vascular Graft Market Attractiveness, by Source, 2016-2024
FIG 16: Global Vascular Graft Market, By Synthetic Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 17: Global Vascular Graft Market, By Biological Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 18: Global Vascular Graft Market, Biosynthetic Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 19: Global Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 20: Global Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 21: Global Vascular Graft Market, By Coronary Artery Disease Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 22: Global Vascular Graft Market, By Aneurysm Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 23: Global Vascular Graft Market, By Vascular Occlusion Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 24: Global Vascular Graft Market, By Renal Failure Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 25: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 26: Global Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 27: Global Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 28: Global Vascular Graft Market, by Hospital, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 29: Global Vascular Graft Market, by Ambulatory Surgical Centers, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 30: Global Vascular Graft Market, by Cardiac Catheterization Laboratories, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 31: Global Vascular Graft Market, by Specialty Clinics, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 32: Global Vascular Graft Market, By Others Segment Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 33: Global Vascular Graft Market Value Share, by Region, 2016 and 2024
FIG 34: Global Vascular Graft Market Attractiveness, by Region, 2016-2024
FIG 35: North America Vascular Graft Market (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 36: North America Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 37: North America Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG38: North America Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 39: North America Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 40: North America Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 41: North America Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 42: North America Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 43: North America Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 44: North America Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 45: North America Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 46: Europe Vascular Graft Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 47: Europe Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 48: Europe Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 49: Europe Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 50: Europe Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 51: Europe Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 52: Europe Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 53: Europe Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 54: Europe Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 55: Europe Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 56: Europe Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 57: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2014–2024
FIG 58: Asia Pacific Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 59: Asia Pacific Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 60: Asia Pacific Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 61: Asia Pacific Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 62: Asia Pacific Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 63: Asia Pacific Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 64: Asia Pacific Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 65: Asia Pacific Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 66: Asia Pacific Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 67: Asia Pacific Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 68: Latin America Vascular Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG 69: Latin America Vascular Graft Market Attractiveness Analysis, by Country, 2016–2024
FIG 70: Latin America Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 71: Latin America Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 72: Latin America Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 73: Latin America Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 74: Latin America Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 75: Latin America Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 76: Latin America Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 77: Latin America Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 78: Latin America Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 79: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, 2014–2024
FIG 80: Middle East & Africa Vascular Graft Market Attractiveness, by Country, 2016–2024
FIG 81: Middle East & Africa Vascular Graft Market Value Share, by Product, 2016 and 2024
FIG 82: Middle East & Africa Vascular Graft Market Attractiveness, by Product, 2016–2024
FIG 83: Middle East & Africa Vascular Graft Market Value Share, by Source, 2016 and 2024
FIG 84: Middle East & Africa Vascular Graft Market Attractiveness, by Source, 2016–2024
FIG 85: Middle East & Africa Vascular Graft Market Value Share, by Application, 2016 and 2024
FIG 86: Middle East & Africa Vascular Graft Market Attractiveness, by Application, 2016-2024
FIG 87: Middle East & Africa Vascular Graft Market Value Share, by End-user, 2016 and 2024
FIG 88: Middle East & Africa Vascular Graft Market Attractiveness, by End-user, 2016-2024
FIG 89: Middle East & Africa Vascular Graft Market Value Share, by Country, 2016 and 2024
FIG 90: Global Vascular Graft Market Share Analysis, by Company (2016) 

List of Tables

Table 01: Global Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 02: Global Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 03: Global Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 04: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 05: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 06: Global Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 07: Global Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 08: Global Vascular Graft Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 09: North America Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 10: North America Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 11: North America Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 12: North America Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 13: North America Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 14: North America Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 15: North America Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 16: North America Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 18: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 19: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 20: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 21: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 22: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 23: Europe Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 24: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 25: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 26: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 27: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 28: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 29: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 30: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 31: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 32: Asia Pacific Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 33: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 34: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 35: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 36: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 37: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 38: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 39: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 40: Latin America Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 41: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 42: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2014–2024
Table 43: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic Source, 2014–2024
Table 44: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Biological Source, 2014–2024
Table 45: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic Source, 2014–2024
Table 46: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 47: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 48: Middle East & Africa Vascular Graft Market Size (US$ Mn) Forecast, by Country, 2014–2024

 

Global Vascular Graft Market: Overview 

This report on the vascular graft market analyzes the current and future scenario of the global market. Large number of cardiovascular disease patient and diabetes sufferers is increasing the usage of vascular grafts. Compatible and high definition designed technology are the major drivers of the global vascular graft market. 

The vascular graft market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on products, source, application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global vascular graft market.  

Global Vascular Graft Market: Segmentation 

Based on product, the market has been segmented into endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft, and others. The product market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by vascular surgeons and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. 

Based on End-user, the vascular graft market has been segmented into four major categories: hospitals, ambulatory surgical centers, specialty clinics, cardiac catheterization laboratories, and others. The vascular grafts are also segmented into source (synthetic, biological and biosynthetic) and application (coronary artery disease; aneurysm; vascular occlusion; renal failure, and others).  The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Vascular Graft Market: Regional Outlook 

Geographically, the global vascular graft market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players in the global vascular graft market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include W. L. Gore & Associates, Inc., C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG (Getinge Group), Cook Medical, Inc., B. Braun Melsungen AG, Medtronic plc, LeMaitre Vascular, Inc., Vascutek Ltd. (Terumo Company), and others.

The global vascular graft market has been segmented as follows: 

Global Vascular graft Market Revenue, by Product

  • Endovascular Stent Graft
  • Peripheral Vascular Graft
  • Hemodialysis Access Graft
  • Bypass Graft
  • Others

Global Vascular graft Market Revenue, by Application

  • Coronary Artery Disease
  • Aneurysm
  • Vascular Occlusion
  • Renal Failure
  • Others

Global Vascular graft Market Revenue, by Source

  • Synthetic
    • Polytetrafluethylene (PTFE)
    • Polyurethane (PU)
    • Dacron
    • Others
  • Biological
    • Bovine Vein
    • Saphenous Vein
    • Others
  • Biosynthetic
    • Ovine Collagen with Polyester
    • Others

Global Vascular graft Market Revenue, by End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Specialty Clinics
  • Others

Global Vascular graft Market Revenue, By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
  • Rest of Middle East & Africa


 
 
Back To Top